Market Cap 122.13B
Revenue (ttm) 48.30B
Net Income (ttm) -8.95B
EPS (ttm) N/A
PE Ratio 51.67
Forward PE 8.73
Profit Margin -18.53%
Debt to Equity Ratio 3.03
Volume 11,616,126
Avg Vol 12,115,670
Day's Range N/A - N/A
Shares Out 2.03B
Stochastic %K 55%
Beta 0.43
Analysts Sell
Price Target $60.65

Latest News on BMY

Final Trade: DIS, BMY, AMZN, XMAG

Mar 28, 2025, 6:21 PM EDT - 3 days ago

Final Trade: DIS, BMY, AMZN, XMAG

AMZN DIS XMAG


10 Undervalued Dividend Growth Stocks: March 2025

Mar 19, 2025, 9:00 AM EDT - 12 days ago

10 Undervalued Dividend Growth Stocks: March 2025

MGA O PFE PRU TGT TROW UPS


Bristol-Myers Squibb: Why I'm Still Bullish

Mar 18, 2025, 5:09 PM EDT - 13 days ago

Bristol-Myers Squibb: Why I'm Still Bullish


Final Trade: VRSK, BMY, VZ, APO, GM

Mar 10, 2025, 6:19 PM EDT - 21 days ago

Final Trade: VRSK, BMY, VZ, APO, GM

GM APO VRSK


I'm Locking 9-11% FCF Yields On These Dividend Icons

Mar 8, 2025, 8:00 AM EST - 23 days ago

I'm Locking 9-11% FCF Yields On These Dividend Icons

ARE


Final Trade: SBUX, GAP, SLV, BMY

Mar 6, 2025, 6:35 PM EST - 25 days ago

Final Trade: SBUX, GAP, SLV, BMY

GAP SBUX SLV


Bristol Myers Squibb Announces Dividend

Mar 3, 2025, 4:16 PM EST - 4 weeks ago

Bristol Myers Squibb Announces Dividend


U.S.

Feb 24, 2025, 6:59 AM EST - 5 weeks ago

U.S.


Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology Success

Feb 21, 2025, 3:36 PM EST - 5 weeks ago

Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology Success


What's Going On With Bristol Myers Squibb Stock On Monday?

Feb 10, 2025, 10:41 AM EST - 7 weeks ago

What's Going On With Bristol Myers Squibb Stock On Monday?


Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook

Feb 6, 2025, 12:08 PM EST - 7 weeks ago

Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook


Cramer's Mad Dash: Bristol Myers

Feb 6, 2025, 9:50 AM EST - 7 weeks ago

Cramer's Mad Dash: Bristol Myers


Trade Tracker: Josh Brown buys Bristol-Myers

Feb 4, 2025, 1:28 PM EST - 7 weeks ago

Trade Tracker: Josh Brown buys Bristol-Myers